Viewing Study NCT00002120



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00002120
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: Randomized Phase I Study of Trimetrexate Glucuronate TMTX With Leucovorin LCV Protection Plus Dapsone Versus Trimethoprim Sulfamethoxazole TMPSMX for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia
Sponsor: US Bioscience
Organization: NIH AIDS Clinical Trials Information Service

Study Overview

Official Title: Randomized Phase I Study of Trimetrexate Glucuronate TMTX With Leucovorin LCV Protection Plus Dapsone Versus Trimethoprim Sulfamethoxazole TMPSMX for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia
Status: COMPLETED
Status Verified Date: 1996-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the safety of the combination of trimetrexate glucuronate TMTX and dapsone with leucovorin protection versus trimethoprimsulfamethoxazole TMPSMX in patients with AIDS and moderately severe Pneumocystis carinii pneumonia PCP To determine the pharmacokinetic parameters of TMTX leucovorin and dapsone and of TMPSMX when given to patients with AIDS and moderately severe PCP
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
Secondary ID Type Domain Link
TMTX A009 None None None